These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

782 related items for PubMed ID: 21069266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
    Bolzoni M, Donofrio G, Storti P, Guasco D, Toscani D, Lazzaretti M, Bonomini S, Agnelli L, Capocefalo A, Dalla Palma B, Neri A, Nicolini F, Lisignoli G, Russo F, Colla S, Aversa F, Giuliani N.
    Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
    [Abstract] [Full Text] [Related]

  • 3. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
    Liu Y, Rubin B, Bodine PV, Billiard J.
    J Cell Biochem; 2008 Oct 01; 105(2):497-502. PubMed ID: 18615587
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
    Lee SE, Lim SD, Kang SY, Suh SB, Suh YL.
    Brain Pathol; 2013 Jul 01; 23(4):445-53. PubMed ID: 23278988
    [Abstract] [Full Text] [Related]

  • 5. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
    Maeda K, Kobayashi Y, Udagawa N, Uehara S, Ishihara A, Mizoguchi T, Kikuchi Y, Takada I, Kato S, Kani S, Nishita M, Marumo K, Martin TJ, Minami Y, Takahashi N.
    Nat Med; 2012 Feb 19; 18(3):405-12. PubMed ID: 22344299
    [Abstract] [Full Text] [Related]

  • 6. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
    Mikels AJ, Nusse R.
    PLoS Biol; 2006 Apr 19; 4(4):e115. PubMed ID: 16602827
    [Abstract] [Full Text] [Related]

  • 7. Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases.
    Minami Y, Oishi I, Endo M, Nishita M.
    Dev Dyn; 2010 Jan 19; 239(1):1-15. PubMed ID: 19530173
    [Abstract] [Full Text] [Related]

  • 8. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
    Endo M, Nishita M, Fujii M, Minami Y.
    Int Rev Cell Mol Biol; 2015 Jan 19; 314():117-48. PubMed ID: 25619716
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
    Li L, Ying J, Tong X, Zhong L, Su X, Xiang T, Shu X, Rong R, Xiong L, Li H, Chan AT, Ambinder RF, Guo Y, Tao Q.
    Cell Mol Life Sci; 2014 Jun 19; 71(11):2179-92. PubMed ID: 24158497
    [Abstract] [Full Text] [Related]

  • 10. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
    Flores-Hernández E, Velázquez DM, Castañeda-Patlán MC, Fuentes-García G, Fonseca-Camarillo G, Yamamoto-Furusho JK, Romero-Avila MT, García-Sáinz JA, Robles-Flores M.
    Cell Signal; 2020 Aug 19; 72():109636. PubMed ID: 32283254
    [Abstract] [Full Text] [Related]

  • 11. Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling.
    Mikels A, Minami Y, Nusse R.
    J Biol Chem; 2009 Oct 30; 284(44):30167-76. PubMed ID: 19720827
    [Abstract] [Full Text] [Related]

  • 12. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH.
    World J Gastroenterol; 2012 Mar 28; 18(12):1328-38. PubMed ID: 22493546
    [Abstract] [Full Text] [Related]

  • 13. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M, Minami Y.
    Oncogene; 2009 Sep 10; 28(36):3197-208. PubMed ID: 19561643
    [Abstract] [Full Text] [Related]

  • 14. Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization.
    Nishita M, Itsukushima S, Nomachi A, Endo M, Wang Z, Inaba D, Qiao S, Takada S, Kikuchi A, Minami Y.
    Mol Cell Biol; 2010 Jul 10; 30(14):3610-9. PubMed ID: 20457807
    [Abstract] [Full Text] [Related]

  • 15. Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2.
    Witte F, Bernatik O, Kirchner K, Masek J, Mahl A, Krejci P, Mundlos S, Schambony A, Bryja V, Stricker S.
    FASEB J; 2010 Jul 10; 24(7):2417-26. PubMed ID: 20215527
    [Abstract] [Full Text] [Related]

  • 16. Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation.
    Fu HD, Wang BK, Wan ZQ, Lin H, Chang ML, Han GL.
    J Mol Histol; 2016 Oct 10; 47(5):455-66. PubMed ID: 27456852
    [Abstract] [Full Text] [Related]

  • 17. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
    Nishita M, Yoo SK, Nomachi A, Kani S, Sougawa N, Ohta Y, Takada S, Kikuchi A, Minami Y.
    J Cell Biol; 2006 Nov 20; 175(4):555-62. PubMed ID: 17101698
    [Abstract] [Full Text] [Related]

  • 18. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2.
    Yamamoto H, Yoo SK, Nishita M, Kikuchi A, Minami Y.
    Genes Cells; 2007 Nov 20; 12(11):1215-23. PubMed ID: 17986005
    [Abstract] [Full Text] [Related]

  • 19. Stable genetic alterations of β-catenin and ROR2 regulate the Wnt pathway, affect the fate of MSCs.
    Cai SX, Liu AR, He HL, Chen QH, Yang Y, Guo FM, Huang YZ, Liu L, Qiu HB.
    J Cell Physiol; 2014 Jun 20; 229(6):791-800. PubMed ID: 24590964
    [Abstract] [Full Text] [Related]

  • 20. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
    O'Connell MP, Fiori JL, Xu M, Carter AD, Frank BP, Camilli TC, French AD, Dissanayake SK, Indig FE, Bernier M, Taub DD, Hewitt SM, Weeraratna AT.
    Oncogene; 2010 Jan 07; 29(1):34-44. PubMed ID: 19802008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.